Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002
Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
Bronchial hyperresponsiveness (BHR) in children with allergic rhinitis (AR) and its relationship to exhaled nitric oxide (FeNO) Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Optimising inhaled corticosteroid (ICS) dose using exhaled nitric oxide (eNO) measurements Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003
Atopy but no bronchial hyperresponsiveness (BHR) is related to level of exhaled nitric oxide (FeNO) in children with allergic rhinitis Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008
Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 270s Year: 2004
Increased exhaled nitric oxide (E-NO) in asthmatics with bronchial hyperreactivity to MCh and UNDW Source: Eur Respir J 2001; 18: Suppl. 33, 164s Year: 2001
Stability of exhaled nitric oxide (FE NO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008
The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Source: Eur Respir J 2002; 20: 853-858 Year: 2002
Are exhaled nitric oxide and airway hyperresponsiveness good predictive markers of inhaled corticosteroids dose reduction failures in children? Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma Year: 2003
The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO ) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004
Increased small airway involvement in asthma compared to those with rhinitis and bronchial hyperresponsiveness, measured by fractional nitric oxide (NO) and impulse oscillometry (IOS) Source: Eur Respir J 2005; 26: Suppl. 49, 735s Year: 2005
Peak flow variation, exhaled nitric oxide and sputum eosinophils correlate with airway hyperresponsiveness to mannitol and methacholine in steroid-naïve asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 366s Year: 2007
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009
Increased serum levels of IL-8 and TNFα in severe asthma compared to mild asthma: relationship with airway calibre and exhaled nitric oxide (FeNO) Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004